Overview

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Status:
RECRUITING

Trial end date:
2026-10-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of GP-asPNA for in vivo treatment of severe antibiotic resistant bacterial keratitis.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

Eye & ENT Hospital of Fudan University

Collaborator:

Soochow University